Welcome to the 7th German-French DNA Repair

Dear Colleagues,

We are delighted to announce the 7th German-French DNA Repair Meeting, which will take place at the Campus Pierre et Marie Curie of Sorbonne University in Paris, France, from 5–7 November 2025.

This 2½-day meeting will bring together leading scientists in the fields of DNA damage repair, (epi)genome maintenance, replication stress, chromatin function and dynamics, and cancer research.

The program will feature 8 plenary talks delivered by renowned international speakers, 25 short talks selected from submitted abstracts, and poster presentations, with awards for the best posters.

Our goal is to provide a platform for the German and French DNA repair communities to foster collaborations in genome stability and related fields. We especially encourage students and early-career scientists to present their work and connect with peers and experts.

To enhance scientific exchange, we have also planned social events:

November 5: A welcome cocktail on the rooftop of the Pierre et Marie Curie Campus, offering a panoramic view of Paris.

November 6: A gala dinner in the heart of Paris.

We are confident that this exciting meeting will offer excellent opportunities for scientific discussions, networking, and collaboration.

We look forward to welcoming you to Paris in November 2025!

Sincerely,

The Organizing Committee

German French DNA 5th edition

German French DNA 6th edition

The meeting will cover cutting-edge research at the intersection of genome stability, chromatin dynamics, and DNA repair. Topics will include the molecular and structural biology of DNA repair, the 3D genome organization in repair mechanisms, chromatin remodeling and its interplay with DNA repair, the compartmentalization of the DNA damage response, the genomics of DNA damage and mutational processes, checkpoint signaling and control of cell fate, as well as the molecular basis of cell growth and division. Additionally, the meeting will highlight how structure-based drug design is driving the development of novel therapeutic approaches targeting DNA repair pathways in cancer.